The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.

Amber Tong

Editor at Endpoints News

Her coverage varies daily but as a Hong Kong native, she is particularly excited about drug development in China. A graduate of Rice University, her work has appeared in Houstonia Magazine, Governing Magazine and The Chautauquan Daily. Amber is based in Hong Kong.

 amber-pak-wei-tong-5aa385bb

 AmberTongPW

See also

Endpoints News

News provider covering bipharma’s most comprehensive daily news and updates

Details last updated 02-Aug-2020

Articles written by Amber Tong

Terray Therapeutics unveils game-changing platform for drug discovery

Terray Therapeutics unveils game-changing platform for drug discovery

Endpoints News - 15-Feb-2022

Combining AI with innovative chemistry to tackle the data bottleneck in medicine development

Omega Therapeutics raises $85m for Epigenomic Controllers

Omega Therapeutics raises $85m for Epigenomic Controllers

Endpoints News - 29-Jul-2020

New gene expression therapy for various targets, with clinical trial planned for 2021